VIRX logo

Viracta Therapeutics, Inc. (VIRX)

Profile

Full Name

Viracta Therapeutics, Inc.

Ticker

NASDAQ: VIRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 27, 2005

Indexes

Not included

Website

https://www.viracta.com

Employees

26

Key Details

Price

$0.01(0.00%)

Market Cap

$389.49K(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$1.32(-1.54% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.01
    VIRX price is $0.01

    30-Day Relative Volume

    -
    VIRX 30-day relative volume value is unknown

    Price Performance

    Price Most Recent Change

    0%
    VIRX price has remained unchanged on Dec 8, 2025

    Price YTD Change

    -93.88%
    VIRX price is down -93.88% since January 1st

    Price 1-Year Change

    -93.88%
    VIRX price is down -93.88% year-on-year

    Price 3-Year Change

    -99.46%
    VIRX price is down -99.46% over the past 3 years

    Price Range

    Price All-Time High

    $9347.37
    VIRX price is currently -100.00% below its historical high of $9347.37

    Price 3-Year Low

    $0.01
    VIRX price is currently +22.50% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $389.49K
    VIRX market cap is $389.49 thousand

    Market Cap 3-Year Change

    -99.43%
    VIRX market cap is down -99.43% over the past 3 years

    Market Cap All-Time High

    $580.82M
    VIRX market cap is currently -99.93% below its historical high of $580.82 million

    Market Cap Sector Percentile

    3.65%
    VIRX market cap is higher than 3.65% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    VIRX shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +4.05%
    VIRX shares outstanding is up +4.05% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.00
    VIRX beta is 1.00

    200-day SMA

    $0.02
    VIRX price is currently -36.77% below its 200-day simple moving average

    50-day SMA

    $0.01
    VIRX price is currently equal to its 50-day simple moving average

    14-Day RSI

    50.00
    VIRX 14-day relative strength index is 50.00

    Volume

    -
    VIRX 30-day relative volume value is unknown

    ATR

    $0.00
    VIRX average true range is $0.00

    10-day Historical Volatility

    0.00%
    VIRX 10-day historical volatility is 0.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    VIRX annual revenue value is unknown

    Revenue Analysts Estimate

    -
    VIRX annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    -
    VIRX annual revenue 1-year change is unknown

    Revenue Sector Percentile

    -
    VIRX annual revenue is unknown

    EPS

    EPS

    -$1.32
    VIRX annual earnings per share is -$1.32

    EPS Analysts Estimate

    -
    VIRX annual earnings per share consensus analysts' forecast is unknown

    EPS 1-Year Change

    -1.54%
    VIRX annual earnings per share is down -1.54% year-on-year

    EPS Sector Percentile

    49.08%
    VIRX annual earnings per share is higher than 49.08% of companies in Healthcare sector

    Profit

    Gross Profit

    -
    VIRX annual gross profit value is unknown

    Gross Margin

    -
    VIRX annual gross profit margin value is unknown

    Operating Profit

    -$50.69M
    VIRX annual operating income is -$50.69 million

    Operating Margin

    -
    VIRX annual operating profit margin value is unknown

    Net Income

    -$51.06M
    VIRX annual net profit is -$51.06 million

    Net Margin

    -
    VIRX annual net profit margin value is unknown

    Expenses

    Total Expenses

    $50.69M
    VIRX annual total expenses is $50.69 million

    Operating Expenses

    $50.69M
    VIRX annual total operating expenses is $50.69 million

    Cost Of Goods Sold

    -
    VIRX annual cost of goods sold value is unknown

    Selling, General & Administrative Expenses

    $17.32M
    VIRX annual SG&A is $17.32 million

    Depreciation & Amortization

    $492.00K
    VIRX annual D&A is $492.00 thousand

    Interest Expense

    $3.70M
    VIRX annual interest expense is $3.70 million

    Income Tax

    -
    VIRX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$47.35M
    VIRX annual earnings before interest & taxes is -$47.35 million

    EBITDA

    -$46.86M
    VIRX annual EBITDA is -$46.86 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $56.69M
    VIRX annual total assets is $56.69 million

    Non Current Assets

    $1.73M
    VIRX annual long term assets is $1.73 million

    Current Assets

    $54.96M
    VIRX annual total current assets is $54.96 million

    Cash and Cash Equivalents

    $12.32M
    VIRX annual cash & cash equivalents is $12.32 million

    Accounts Receivable

    -
    VIRX annual accounts receivable value is unknown

    Inventory

    -
    VIRX annual inventory value is unknown

    Liabilities

    Total Liabilities

    $38.37M
    VIRX annual total liabilities is $38.37 million

    Long Term Liabilities

    $0.00
    VIRX annual total long term liabilities is $0.00

    Current Liabilities

    $38.37M
    VIRX annual current liabilities is $38.37 million

    Accounts Payable

    $2.44M
    VIRX annual accounts payable is $2.44 million

    Debt

    Total Debt

    $25.56M
    VIRX annual total debt is $25.56 million

    Total Debt 1-Year Change

    +1.59%
    VIRX annual total debt is up +1.59% year-on-year

    Long Term Debt

    -
    VIRX annual long term debt value is unknown

    Short Term Debt

    $25.56M
    VIRX annual short term debt is $25.56 million

    Equity & Capital

    Shareholders Equity

    $18.32M
    VIRX annual stockholders equity is $18.32 million

    Book Value

    $12.87M
    VIRX annual book value is $12.87 million

    Retained Earnings

    -$265.93M
    VIRX annual retained earnings is -$265.93 million

    Working Capital

    $16.59M
    VIRX annual working capital is $16.59 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$39.89M
    VIRX annual cash from operations is -$39.89 million

    Cash From Operations 1-Year Change

    -12.51%
    VIRX annual cash from operations is down -12.51% year-on-year

    Cash From Investing

    $15.00M
    VIRX annual cash from investing is $15.00 million

    Cash From Investing 1-Year Change

    +127.84%
    VIRX annual cash from investing is up +127.84% year-on-year

    Cash From Financing

    $438.00K
    VIRX annual cash from financing is $438.00 thousand

    Cash From Financing 1-Year Change

    -98.06%
    VIRX annual cash from financing is down -98.06% year-on-year

    CAPEX

    CAPEX

    -
    VIRX annual capital expenditures value is unknown

    CAPEX 1-Year Change

    -
    VIRX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free Cash Flow

    -$40.03M
    VIRX annual free cash flow is -$40.03 million

    Free Cash Flow 1-Year Change

    -12.75%
    VIRX annual free cash flow is down -12.75% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    VIRX annual gross profit margin value is unknown

    Operating Margin

    -
    VIRX annual operating profit margin value is unknown

    Net Margin

    -
    VIRX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -90.06%
    VIRX annual return on assets is -90.06%

    ROE

    -278.72%
    VIRX annual return on equity is -278.72%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    VIRX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    VIRX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -0.06
    VIRX price to book ratio is -0.06

    PB Ratio Sector Percentile

    14.92%
    VIRX price to book ratio is higher than 14.92% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    VIRX price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    VIRX price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $4.17M
    VIRX enterprise value is $4.17 million

    Enterprise Value Sector Percentile

    15.87%
    VIRX enterprise value is higher than 15.87% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.11
    VIRX EV/EBITDA is -0.11

    EV/EBITDA Sector Percentile

    60.55%
    VIRX EV/EBITDA is higher than 60.55% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.43
    VIRX annual current ratio is 1.43

    Quick Ratio

    -
    VIRX annual quick ratio value is unknown

    Leverage

    Debt To Equity

    1.40
    VIRX annual debt to equity ratio is 1.40

    Interest Coverage Ratio

    -12.78
    VIRX annual interest coverage ratio is -12.78

    Risk & Stability

    F-Score

    -
    VIRX piotroski f-score value is unknown

    Altman Z-Score

    -
    VIRX altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Dec 27, 24 Rodman & Renshaw
    Neutral
    Nov 14, 24 RBC Capital
    Outperform
    Aug 16, 24 Leerink Partners
    Market Perform
    Aug 15, 24 RBC Capital
    Outperform
    May 23, 24 Oppenheimer
    Outperform
    Apr 17, 24 Oppenheimer
    Outperform
    Apr 16, 24 HC Wainwright & Co.
    Buy
    Mar 12, 24 HC Wainwright & Co.
    Buy
    Jan 5, 24 HC Wainwright & Co.
    Buy
    Nov 10, 23 RBC Capital
    Outperform

    Institutional Ownership

    Screeners with VIRX included

    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Viracta Therapeutics, Inc.?
    • Does Viracta Therapeutics, Inc. pay dividends?
    • What sector is Viracta Therapeutics, Inc. in?
    • What industry is Viracta Therapeutics, Inc. in?
    • What country is Viracta Therapeutics, Inc. based in?
    • When did Viracta Therapeutics, Inc. go public?
    • Is Viracta Therapeutics, Inc. in the S&P 500?
    • Is Viracta Therapeutics, Inc. in the NASDAQ 100?
    • Is Viracta Therapeutics, Inc. in the Dow Jones?
    • When was Viracta Therapeutics, Inc.'s last earnings report?
    • When does Viracta Therapeutics, Inc. report earnings?

    What is the ticker symbol for Viracta Therapeutics, Inc.?

    The ticker symbol for Viracta Therapeutics, Inc. is NASDAQ:VIRX

    Does Viracta Therapeutics, Inc. pay dividends?

    No, Viracta Therapeutics, Inc. does not pay dividends

    What sector is Viracta Therapeutics, Inc. in?

    Viracta Therapeutics, Inc. is in the Healthcare sector

    What industry is Viracta Therapeutics, Inc. in?

    Viracta Therapeutics, Inc. is in the Biotechnology industry

    What country is Viracta Therapeutics, Inc. based in?

    Viracta Therapeutics, Inc. is headquartered in United States

    When did Viracta Therapeutics, Inc. go public?

    Viracta Therapeutics, Inc.'s initial public offering (IPO) was on September 27, 2005

    Is Viracta Therapeutics, Inc. in the S&P 500?

    No, Viracta Therapeutics, Inc. is not included in the S&P 500 index

    Is Viracta Therapeutics, Inc. in the NASDAQ 100?

    No, Viracta Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Viracta Therapeutics, Inc. in the Dow Jones?

    No, Viracta Therapeutics, Inc. is not included in the Dow Jones index

    When was Viracta Therapeutics, Inc.'s last earnings report?

    Viracta Therapeutics, Inc.'s most recent earnings report was on August 6, 2025

    When does Viracta Therapeutics, Inc. report earnings?

    The date for Viracta Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page